- Filed
- May 14, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 30, 2025 | 37.44M sh |
| Shares Diluted | Q1 2025 · Mar 31, 2025 | 41.68M sh |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 3.2M sh |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $83.57M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $61.58M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $11.72M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $13.04M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $12.39M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $13.8M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $352.08M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $376.87M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $377.11M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $396.02M |
| Eps Diluted | Q1 2025 · Mar 31, 2025 | −$0.40 |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$2.21 |
| Eps Basic | Q1 2025 · Mar 31, 2025 | −$0.40 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$2.21 |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$168K |
| Stockholders Equity restated | Q1 2025 · Mar 31, 2024 | −$7.06M |
| Stockholders Equity | Q1 2025 · Feb 5, 2024 | $1K |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $5.19M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$7.08M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$6.86M |